National Biopharmaceutical Alliance Group Purchasing Starts, Including 8 varieties.

The Anhui Provincial Medical Price and Centralized Procurement Center recently issued a notice on the collection of information on some monoclonal antibody biosimilars, targeting the collection of information on 8 monoclonal antibody biosimilars such as adalimumab and infliximab. As early as January of this year, the Anhui Provincial Medical Insurance Bureau issued information that Anhui Province will lead the national biopharmaceutical alliance in centralized procurement. Although it is currently only in the information collection stage, it is seen within the industry that the national biopharmaceutical alliance procurement has begun.